Article info
PDFBrief report
A proposed non-consequentialist policy for the ethical distribution of scarce vaccination in the face of an influenza pandemic
- Correspondence to Professor Hugh V McLachlan, Glasgow School for Business and Society, Glasgow Caledonian University, Glasgow G4 0BA, UK; h.mclachlan{at}gcal.ac.uk
Citation
A proposed non-consequentialist policy for the ethical distribution of scarce vaccination in the face of an influenza pandemic
Publication history
- Received June 7, 2011
- Revised January 12, 2012
- Accepted January 16, 2012
- First published March 12, 2012.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- On the random distribution of scarce doses of vaccine in response to the threat of an influenza pandemic: a response to Wardrope
- Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10
- Vaccine ethics: an ethical framework for global distribution of COVID-19 vaccines
- Scarce vaccine supplies in an influenza pandemic should not be distributed randomly: reply to McLachlan
- Socioeconomic, cultural and behavioural features of prior and anticipated influenza vaccine uptake in urban and rural Pune district, India: a mixed-methods case study
- Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
- Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study
- Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
- Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009
- COVID-19 vaccine barriers and perception among rural adults: a qualitative study in Bangladesh